MS

Michel Sadelain

MC Memorial Sloan Kettering Cancer Center: 32 patents #3 of 761Top 1%
SR Sloan Kettering Institute For Cancer Research: 5 patents #84 of 644Top 15%
MP Millennium Pharmaceuticals: 1 patents #496 of 771Top 65%
MD Memorial Hospital For Cancer And Allied Diseases: 1 patents #4 of 27Top 15%
UW University Of Washington: 1 patents #985 of 2,234Top 45%
📍 New York, NY: #336 of 20,192 inventorsTop 2%
🗺 New York: #3,082 of 115,490 inventorsTop 3%
Overall (All Time): #92,010 of 4,157,543Top 3%
36
Patents All Time

Issued Patents All Time

Showing 1–25 of 36 patents

Patent #TitleCo-InventorsDate
12404316 Transgenic T cell and chimeric antigen receptor T cell compositions and related methods Justin Eyquem, Jorge Mansilla-Soto 2025-09-02
12345712 Cancer antigen targets and uses thereof Fabiana Perna 2025-07-01
12331129 Chimeric receptors targeting ADGRE2 and/or CLEC12A and uses thereof Sascha P. Haubner, Jorge Mansilla-Soto, Xingyue He, Gary Shapiro 2025-06-17
12275802 Compositions and methods for immunotherapy Victor D. Fedorov 2025-04-15
12263220 Compositions and methods for immunotherapy Christopher C. Kloss 2025-04-01
12259390 Cancer antigen targets and uses thereof Fabiana Perna 2025-03-25
12139524 Immune cell compositions and methods of use Prasad S. Adusumilli 2024-11-12
12036244 Cells comprising non-HLA restricted T cell receptors Jorge Mansilla-Soto, Justin Eyquem, Anton Dobrin 2024-07-16
12018077 Methods of treatments using antigen-binding proteins targeting CD56 Reuben Benjamin, Dimiter S. Dimitrov, Yang Feng 2024-06-25
11932690 Enhanced chimeric antigen receptors and uses thereof Judith Feucht, Mohamad Hamieh, Jie Sun, Jorge Mansilla-Soto 2024-03-19
11753654 Globin gene therapy for treating hemoglobinopathies Annalisa Cabriolu 2023-09-12
11717579 Globin gene therapy for treating hemoglobinopathies Isabelle Riviere, Jorge Mansilla-Soto, Xiuyan Wang, George Stamatoyannopoulos, John A. Stamatoyannopoulos +1 more 2023-08-08
11712469 Compositions and methods for immunotherapy Christopher C. Kloss 2023-08-01
11702472 Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors Prasad S. Adusumilli, Dimiter S. Dimitrov, Yang Feng 2023-07-18
11377637 Transgenic T cell and chimeric antigen receptor T cell compositions and related methods Justin Eyquem, Jorge Mansilla-Soto 2022-07-05
11267901 Compositions and methods for immunotherapy Victor D. Fedorov 2022-03-08
11242375 Immune cell compositions and methods of use Prasad S. Adusumilli 2022-02-08
11229669 Cells comprising non-HLA restricted T cell receptors Jorge Mansilla-Soto, Justin Eyquem, Anton Dobrin 2022-01-25
11193938 Cancer antigen targets and uses thereof Fabiana Perna 2021-12-07
11077140 Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes Matthias Stephan 2021-08-03
10730941 Antigen-binding proteins targeting CD56 and uses thereof Reuben Benjamin, Dimiter S. Dimitrov, Yang Feng 2020-08-04
10654928 Compositions and methods for immunotherapy Christopher C. Kloss 2020-05-19
10633441 Mesothelin-targeted chimeric antigen receptors and uses thereof Prasad S. Adusumilli, Dimiter S. Dimitrov, Yang Feng 2020-04-28
10538588 Mesothelin-targeted chimeric antigen receptors and methods of making them Prasad S. Adusumilli, Dimiter S. Dimitrov, Yang Feng 2020-01-21
10370452 Effective generation of tumor-targeted T cells derived from pluripotent stem cells Maria Themeli, Christopher C. Kloss 2019-08-06